OncLiveImmunotherapy in Second-Line Advanced Bladder CancerOncLiveDaniel J. George, MD: 2017 into 2018 is going to be a transition period in bladder cancer, particularly for patients who are in the second-line setting. Still today, many of our patients… Continue reading
Medical XpressRemoving the immunotherapy blindfoldMedical XpressImmunotherapies are promising in theory, but often not in practice. In fact according to experts, they actually only work 10 percent of the time in the treatment of cancer – at best. Yet, … Continue reading
Genetic Literacy Project |
Potential CRISPR setback jolts investors, but researchers say there’s no need to panic
Genetic Literacy Project On [January 8], the world of science awoke to news that suddenly cast uncomfortable doubt on many of the past five years’ major breakthroughs: A new paper had identified a possible barrier to using the revolutionary gene-editing tool CRISPR-Cas9 in … |
Science Daily |
‘Decorated’ stem cells could offer targeted heart repair
Science Daily “Platelets can home in on an injury site and stay there, and even in some cases recruit a body’s own naturally occurring stem cells to the site, but they are a double-edged sword,” says Cheng, associate professor of veterinary medicine and associate … |